Laurene H. Wang

Phase I Dose Escalation Trial Evaluating the Pharmacokinetics, Anti-Human Cytomegalovirus (HCMV) Activity, and Safety of 1263W94 in Human Immunodeficiency Virus-Infected Men with Asymptomatic HCMV Shedding

Jacob Lalezari, Judith A. Aberg, Laurene H. Wang et al. · Antimicrobial Agents and Chemotherapy · 2002 · 148 citations · Full text

Phase I Safety and Pharmacokinetic Trials of 1263W94, a Novel Oral Anti-Human Cytomegalovirus Agent, in Healthy and Human Immunodeficiency Virus-Infected Subjects

Laurene H. Wang, Richard Peck, Yin Yin et al. · Antimicrobial Agents and Chemotherapy · 2003 · 132 citations · Full text

Medicinal Chemistry, Adverse Events, Healthy Subjects +13

Pharmacokinetic and Pharmacodynamic Characteristics of Emtricitabine Support Its Once Daily Dosing for the Treatment of HIV Infection

Laurene H. Wang, John Begley, R. L. St. Claire et al. · AIDS Research and Human Retroviruses · 2004 · 125 citations

Pharmacokinetic and Pharmacodynamic Characteristics of Emtricitabine Support Its Once Daily Dosing for the Treatment of HIV Infection

Laurene H. Wang, John Begley, Robert L. St. Claire et al. · AIDS Research and Human Retroviruses · 2004 · 109 citations

Immunology, Pharmacotherapy, Antiviral Drug +21

Prospective Randomized Trial of Emtricitabine versus Lamivudine Short‐Term Monotherapy in Human Immunodeficiency Virus–Infected Patients

Franck Rousseau, Charles Wakeford, Herve Momméja-Marin et al. · The Journal of Infectious Diseases · 2003 · 65 citations · Full text